The United States Patent and Trademark Office (USPTO) has issued patent US12582797B2 to SANA HEALTH, INC. This patent covers non-pharmaceutical methods and systems for treating symptoms of anxiety and depression. The described method involves exposing individuals to visual and/or auditory stimuli pulsed at specific brain wave frequencies, aiming to reduce symptoms such as pain, anxiety, depression, and sleep disturbances.

This patent grant is primarily informational for entities operating in the medical device and healthcare sectors. While it does not impose new regulatory obligations or compliance deadlines on regulated entities, it signifies intellectual property protection for a novel treatment approach. Companies involved in developing or offering therapeutic devices or treatments for mental health conditions should be aware of this patent's existence and scope.